Patent · US Expired

Composition for oral administration containing pyridazinone compounds

US5942249A · kind A · utility

2Cited by
7References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 28, 1998
Grant dateAug 24, 1999
Priority date
Expiry dateJan 28, 2018

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition for oral administration which contains a pyridazinone compound of the formula (I) ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are each independently a hydrogen atom or a lower alkyl, X is a halogen atom, a cyano or a hydrogen atom, Y is a halogen atom, a trifluoromethyl or a hydrogen atom, and A is a C.sub.1 -C.sub.8 alkylene optionally substituted by hydroxy, or a pharmacologically acceptable salt thereof, and an organic acid. According to the present invention, a composition for oral administration which is stable to heat, light, moisture and the like and which shows improved dissolution and absorption of a pyridazinone compound can be provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.